While the Ultimate Fighting Championship has already officially announced a rematch between Mark Hunt and Alistair Overeem for UFC 209, the bout isn’t quite a finished product -- at least as far as Hunt is concerned.
Hunt told his website, markhunt.tv, that he will only fight Overeem on March 4 in Las Vegas if a special provision is added to the contract in case his opponent fails a drug test.
“My clause will protect me in this instance and take the financial gain of the opponent of caught cheating, ” Hunt said. “That deterrent will protect me and other fighters. I’m pushing for this clause, I want to fight and I am ready. If the fight doesn’t go ahead it’s not my doing.”
Hunt last appeared at UFC 200, where he lost a unanimous decision to Brock Lesnar. It was later revealed that Lesnar tested positive for the anti-estrogen agent clomiphene in both an in- and out-of-competition drug test in relation to the event.
Lesnar was fined $250,000 and suspended for one year, and his victory was overturned to a no contest. However, Hunt believes he should have received part of Lesnar’s $2.5 million purse from UFC 200 and has threatened the promotion with a lawsuit.
Overeem, meanwhile, failed an out-of-competition drug test in 2012 administered by the Nevada Athletic Commission prior to a proposed heavyweight title clash against Junior dos Santos at UFC 146. The Dutchman submitted a sample with a testosterone to epistestosterone (T/E) ratio of 14-to-1, more than double the allowable limit of 6-to-1. Overeem ultimately withdrew from the card.
“I will not fight without this clause. I’ve already fought 3 dopers in a row and I’m not going to fight again without security. All I want is a fair go and an even playing field,” Hunt said.
Hunt and Overeem first fought at Dream 5 in 2008, with Overeem winning via first-round submission. Overeem last competed at UFC 203, where he was knocked out in the first round by Stipe Miocic in a heavyweight title bout. Prior to facing Lesnar, Hunt had earned consecutive first-round stoppages of Antonio Silva and Frank Mir.